Cite
HARVARD Citation
Kyriazoglou, A. et al. (2022). Equivocal evaluation of progressive disease in patients treated with immune checkpoint inhibitors: a challenge for clinical trials and biomarker research. Acta clinica belgica. 77 (2), pp. 406-409. [Online].